Author

T.-K. Li

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Zachayus· 1 shared c. capelli· 1 shared C. Cuevas· 1 shared C. Elly· 1 shared C. Marechal· 1 shared C.-W. Lee· 1 shared E. Compe· 1 shared F. Coin· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Zachayus

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Novel synthetic ecteinascidins exhibit potent anti-melanoma activity by suppressing super-enhancer-driven oncogenic transcription

M. Cigrang, j. Obid, i. Davidson, M. Nogaret, t. ye, g. davidson, P. Catez, P. Berico, c. capelli, C. Marechal, A. Zachayus, C. Elly, T.-K. Li, E. Compe, P. Aviles, , F. Coin

This study shows novel synthetic ecteinascidins effectively treat melanoma by inhibiting super-enhancer-driven oncogenic transcription, even in resistant models.

bioRxiv · Mar 26, 2024 · PreprintCancer Biology

MiR-221/222-enriched ADSC-exosome mitigates PM exposure-exacerbated cardiac ischemia/reperfusion injury through the modulation of the BNIP3/LC3B/PUMA pathway

T.-L. Lee, W.-C. Shen, Y.-C. Chen, T.-C. Lai, S.-R. Lin, S.-W. Lin, I.-S. Yu, Y.-H. Yeh, T.-K. Li, I.-T. Lee, C.-W. Lee, Y.-L. Chen

This study shows that PM exposure worsens cardiac ischemia/reperfusion injury, which is mitigated by ADSC-exosome containing miR-221/222 through modulation of the BNIP3/LC3B/PUMA pathway.

bioRxiv · Nov 10, 2023 · PreprintCell Biology